Publication Name	World Journal of Clinical Oncology
Manuscript ID	11200
Country	India

Received	2014-05-08 20:58
Peer-Review Started	2014-05-09 18:51
To Make the First Decision	2014-07-10 17:25
Return for Revision	2014-07-11 14:30
Revised	2014-12-19 00:55
Second Decision	2015-09-21 17:14
Accepted by Journal Editor-in-Chief	2015-09-23 18:23
Accepted by Executive Editor-in-Chief	2015-10-08 17:45
Articles in Press	2015-10-08 17:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-11-26 15:02
Publish the Manuscript Online	2015-12-09 18:37

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Biomarkers in triple negative breast cancer: A review
Manuscript Source	Unsolicited Manuscript
All Author List	Budhi S Yadav, Priyanka Chanana and Swaty Jhamb
Funding Agency and Grant Number
Corresponding Author	Dr. Budhi S Yadav, Associate Professor, Department of Radiotherapy, PGIMER, Sector 12, Chandigarh 160012, India. drbudhi@gmail.com
Key Words	Triple negative breast cancer; Epidermal growth factor receptor; Vascular endothelial growth factor; p53; Cyclin
Core Tip	Triple negative breast cancer (TNBC) are type of breast cancer which lack of estrogen receptors, progesterone receptors and human epidermal growth factor receptor. It is a complex disease subtype with many subclasses. There are many biomarkers in TNBC used for its sub-classification. Clinically-practical assay/biomarkers that can reliably identify TNBC are necessary. Biomarkers may be useful as prognostic or predictive indicators as well as suggest possible targets for novel therapies.
Publish Date	2015-12-09 18:37
Citation	Yadav BS, Chanana P, Jhamb S. Biomarkers in triple negative breast cancer: A review. World J Clin Oncol 2015; 6(6): 252-263
URL	http://www.wjgnet.com/2218-4333/full/v6/i6/252.htm
DOI	http://dx.doi.org/10.5306/wjco.v6.i6.252

Full Article (PDF)	WJCO-6-252.pdf
Full Article (Word)	WJCO-6-252.doc
Manuscript File	11200-Review.doc
Answering Reviewers	11200-Answering reviewers.pdf
Audio Core Tip	11200-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	11200-Conflict-of-interest statement.pdf
Copyright License Agreement	11200-Copyright assignment.pdf
Peer-review Report	11200-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	11200-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	11200-Scientific misconduct check.pdf
Scientific Editor Work List	11200-Scientific editor work list.pdf